Développez des compétences fondamentales en intelligence artificielle (IA) responsable grâce à des cours autodirigés, animés par des expert·e·s de Mila reconnu·e·s à l’échelle internationale.
Le Fellowship Mila en politiques de l'IA transforme l'expertise approfondie en IA en politiques rigoureuses d'intérêt public. Découvrez la dernière publication Combler la disparité en matière d’expertise : mécanismes de transfert des connaissances pour la réglementation de l’IA par Moritz von Knebel.
Ce programme soutient les startups spécialisées en IA à tout moment de l'année. Bénéficiez de ressources de pointe et d'un accompagnement sur mesure pour accélérer le développement de votre technologie.
Nous utilisons des témoins pour analyser le trafic et l’utilisation de notre site web, afin de personnaliser votre expérience. Vous pouvez désactiver ces technologies à tout moment, mais cela peut restreindre certaines fonctionnalités du site. Consultez notre Politique de protection de la vie privée pour en savoir plus.
Paramètre des cookies
Vous pouvez activer et désactiver les types de cookies que vous souhaitez accepter. Cependant certains choix que vous ferez pourraient affecter les services proposés sur nos sites (ex : suggestions, annonces personnalisées, etc.).
Cookies essentiels
Ces cookies sont nécessaires au fonctionnement du site et ne peuvent être désactivés. (Toujours actif)
Cookies analyse
Acceptez-vous l'utilisation de cookies pour mesurer l'audience de nos sites ?
Lecteur Multimédia
Acceptez-vous l'utilisation de cookies pour afficher et vous permettre de regarder les contenus vidéo hébergés par nos partenaires (YouTube, etc.) ?
In drug discovery, quantitative structure–activity relationship (QSAR) models are widely used to guide Go/No-Go decisions within the Desig… (voir plus)n–Make–Test–Analyze (DMTA) cycle. However, conventional decision heuristics typically rely on a single cutoff, leading to a rigid binary select/discard paradigm. This approach is particularly ill-suited for borderline compounds near the decision boundary, where screening decisions are especially sensitive to prediction uncertainty and premature choices may either discard viable leads or advance likely failures, thereby increasing downstream assay costs. To address this limitation, we propose Regional Selection (RS), an uncertainty-aware three-way decision framework that partitions compounds into Predicted Pass, Predicted Fail, and Predicted Indeterminate regions. By explicitly reserving high-uncertainty compounds for targeted follow-up, RS avoids the pitfalls of premature binary classification. We formalize this framework through Regional Selection Inference (RSI), which casts region assignment as a multiple-hypothesis testing problem. We develop two imple- mentations of RSI: an empirical calibration-based method (RSI-EC), which thresholds uncertainty-normalized scores via empirical calibration, and a conformal selectionbased method (RSI-CS), which constructs conformal p-values for region assignment. RSI-EC is supported by large-sample calibration arguments, whereas RSI-CS provides finite-sample, distribution-free guarantees under exchangeability. Extensive evaluations across 15 high-dimensional QSAR benchmarks show that both RSI procedures reliably control the false discovery rate while maintaining high screening power. In limited-data regimes, RSI-CS yields particularly stable FDR control, whereas RSI-EC can be slightly less conservative; both perform strongly as sample sizes increase. We further study a cost-aware extension that incorporates asymmetric downstream costs through the score construction while keeping the nominal FDR target fixed. This extension introduces a tuning parameter that can reduce realized downstream cost, with dataset-dependent trade-offs against screening power. Overall, RSI offers a mathematically grounded and resource-aware alternative to single-threshold screening, allowing discovery teams to better balance decision confidence with assay budgets.
Survival models can help medical practitioners to evaluate the prognostic importance of clinical variables to patient outcomes such as morta… (voir plus)lity or hospital readmission and subsequently design personalized treatment regimes. Electronic Health Records (EHRs) hold the promise for large-scale survival analysis based on systematically recorded clinical features for each patient. However, existing survival models either do not scale to high dimensional and multi-modal EHR data or are difficult to interpret. In this study, we present a supervised topic model called MixEHR-SurG to simultaneously integrate heterogeneous EHR data and model survival hazard. Our contributions are three-folds: (1) integrating EHR topic inference with Cox proportional hazards likelihood; (2) integrating patient-specific topic hyperparameters using the PheCode concepts such that each topic can be identified with exactly one PheCode-associated phenotype; (3) multi-modal survival topic inference. This leads to a highly interpretable survival topic model that can infer PheCode-specific phenotype topics associated with patient mortality. We evaluated MixEHR-SurG using a simulated dataset and two real-world EHR datasets: the Quebec Congenital Heart Disease (CHD) data consisting of 8,211 subjects with 75,187 outpatient claim records of 1,767 unique ICD codes; the MIMIC-III consisting of 1,458 subjects with multi-modal EHR records. Compared to the baselines, MixEHR-SurG achieved a superior dynamic AUROC for mortality prediction, with a mean AUROC score of 0.89 in the simulation dataset and a mean AUROC of 0.645 on the CHD dataset. Qualitatively, MixEHR-SurG associates severe cardiac conditions with high mortality risk among the CHD patients after the first heart failure hospitalization and critical brain injuries with increased mortality among the MIMIC-III patients after their ICU discharge.
Strong static type systems help programmers eliminate many errors without much burden of supplying type annotations. However, this flexibili… (voir plus)ty makes it highly non-trivial to diagnose ill-typed programs, especially for novice programmers. Compared to classic constraint solving and optimization-based approaches, the data-driven approach has shown great promise in identifying the root causes of type errors with higher accuracy. Instead of relying on hand-engineered features, this work explores natural language models for type error localization, which can be trained in an end-to-end fashion without requiring any features. We demonstrate that, for novice type error diagnosis, the language model-based approach significantly outperforms the previous state-of-the-art data-driven approach. Specifically, our model could predict type errors correctly 62% of the time, outperforming the state-of-the-art Nate's data-driven model by 11%, in a more rigorous accuracy metric. Furthermore, we also apply structural probes to explain the performance difference between different language models.